MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma

Experimental and Molecular Pathology

Volumn 100, Issue 1, 2016, Pages 132-138

  Jing, Peihang ^a   Sa, Na ^a   Liu, Xianfang ^a   Liu, Xiuxiu ^a   Xu, Wei ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

ADAM10; Cell invasion; Cell migration; Hypopharyngeal squamous cell carcinoma(HSCC); MiR 140 5p; Notch1 signaling

Indexed keywords

ADAM10 ENDOPEPTIDASE; MICRORNA; MICRORNA 140 5P; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; MEMBRANE PROTEIN; MIRN140 MICRORNA, HUMAN; NOTCH1 PROTEIN, HUMAN; SECRETASE;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA; HYPOPHARYNX CANCER; IN VITRO STUDY; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MALE; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR INVASION; AGED; CELL MOTION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; PHARYNX CANCER; PHYSIOLOGY; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; AMYLOID PRECURSOR PROTEIN SECRETASES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PHARYNGEAL NEOPLASMS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84951152061     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.12.008     Document Type: Article

References (25)

1. Agrawal N., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Bova R., et al. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 2005, 115:864-869.
3. Crawford H.C., et al. ADAM10 as a therapeutic target for cancer and inflammation. Curr. Pharm. Des. 2009, 15:2288-2299.
4. Davies L., Welch H.G. Epidemiology of head and neck cancer in the United States. Otolaryngol. Head Neck Surg. 2006, 135:451-457.
5. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
6. Fu L., et al. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells. Tumour Biol. 2014, 35:9263-9268.
7. Guo J., et al. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol. Rep. 2012, 28:1709-1718.
8. Hoffman H.T., et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997, 107:1005-1017.
9. Hong K.J., et al. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J. Cell. Physiol. 2014, 229:191-201.
10. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012, 4:143-159.
11. Jones A.V., et al. ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with alphavbeta6 integrin. FEBS Lett. 2013, 587:3529-3534.
12. Kai Y., et al. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. Biochem. Biophys. Res. Commun. 2014, 448:308-314.
13. Leon X., et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999, 21:204-210.
14. Li W., He F. Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer. Biochem. Biophys. Res. Commun. 2014, 450:844-850.
15. Lu J., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
16. Martello G., et al. A microRNA targeting dicer for metastasis control. Cell 2010, 141:1195-1207.
17. Nohata N., et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br. J. Cancer 2011, 105:833-841.
18. Pang R.T., et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010, 31:1037-1044.
19. Rettig E.M., et al. Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status, and high-risk features. Cancer Prev. Res. (Phila.) 2015, 8:287-295.
20. Spector J.G., et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001, 111:1079-1087.
21. Wilmott J.S., et al. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011, 43:657-671.
22. Yang H., et al. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 2013, 58:205-217.
23. Yap L., et al. The opposing roles of NOTCH signalling in head and neck cancer: a mini review. Oral Dis. 2015.
24. Yoshida R., et al. The pathological significance of Notch1 in oral squamous cell carcinoma. Lab. Investig. 2013, 93:1068-1081.
25. Yuan S., et al. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells. Oncol. Rep. 2013, 30:1715-1722.